ENDRA Life Sciences Inc.
No enriched coverage for $NDRA in the last 7 days.
No SEC Form 4 filings for $NDRA in the last 30 days.
See all $NDRA insider activity →ENDRA Life Sciences (NDRA) reported that ASP Isotopes' partner, Tetra4, has entered the commissioning phase of a liquid helium plant at the Virginia Gas Project. The announcement was made in a press release on August 20, 2026, and includes forward-looking statements under U.S. securities laws.
ENDRA Life Sciences Inc. (NDRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 August 17, 2026 ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update ANN ARBOR, Mich., (BUSINESS WIRE) – ENDRA Life Sciences Inc . (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for e
ASP Isotopes plans to merge its subsidiary Noble Africa, which holds South Africa’s Renergen helium and LNG project, with ENDRA Life Sciences to form a publicly listed helium platform called Noble Africa. ASP Isotopes expects ~89% ownership post-close. Management cites 1P helium reserves of 7.2 Bcf and targets Phase 1 output of ~70 Mcf/day helium and 2,500 GJ/day LNG, with estimated revenue and cash gross profit. Closing is targeted for Q4, subject to SEC review and approvals.
Recent NDRA coverage spans financial news, mergers & acquisitions and earnings.
The commissioning phase signals progress toward operational revenue from the helium plant partnership.
Near-term trading focus is the merger pendency (stockholder and regulatory approvals) plus balance-sheet runway from the $3.8M private placement and $50M expected gross proceeds.
Merger terms and timeline create event-driven upside/downside around shareholder approvals and SEC review risk.
ENDRA is positioned as the biotech imaging company that would be combined into a new public helium/LNG vehicle via the proposed merger.
The filing signals a pending strategic combination that can drive deal-spread volatility, voting/closing risk, and potential reverse-split/listing mechanics.
AlphAI scores every news story that mentions NDRA with an AI model for sentiment and relevance, and aggregates insider trades from ENDRA Life Sciences Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
ENDRA Life Sciences (NDRA) reported that ASP Isotopes' partner, Tetra4, has entered the commissioning phase of a liquid helium plant at the Virginia Gas Project. The announcement was made in a press release on August 20, 2026, and includes forward-looking statements under U.S. securities laws.
1 min readENDRA Life Sciences Inc. (NDRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 August 17, 2026 ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update ANN ARBOR, Mich., (BUSINESS WIRE) – ENDRA Life Sciences Inc . (NASDAQ: NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for e
4 min readASP Isotopes plans to merge its subsidiary Noble Africa, which holds South Africa’s Renergen helium and LNG project, with ENDRA Life Sciences to form a publicly listed helium platform called Noble Africa. ASP Isotopes expects ~89% ownership post-close. Management cites 1P helium reserves of 7.2 Bcf and targets Phase 1 output of ~70 Mcf/day helium and 2,500 GJ/day LNG, with estimated revenue and cash gross profit. Closing is targeted for Q4, subject to SEC review and approvals.
5 min readASP Isotopes (NASDAQ:ASPI) and ENDRA Life Sciences (NASDAQ:NDRA) said RedChip will host a July 21, 2026 webinar on Noble Africa, an ASP Isotopes subsidiary holding Renergen’s Virginia Gas Project. The proposed merger with ENDRA could list Noble Africa on Nasdaq as NOBA. CEO Paul Mann will discuss helium and LNG plans, including Phase 1 ramp in 2026.
2 min readENDRA Life Sciences Inc. (NDRA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 ea029523901ex2-1.htm AGREEMENT AND PLAN OF MERGER, DATED AS OF JUNE 25, 2026, BY AND AMONG ENDRA LIFE SCIENCES INC., KRUGER MERGER SUB LLC, RENERGEN LIMITED, NOBLE AFRICA LLC AND ASP ISOTOPES INC Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among ASP ISOTOPES INC., NO
6 min readENDRA Life Sciences (NASDAQ: NDRA) is distinguishing itself through its combination of breakthrough medical imaging innovation, specifically the TAEUS® system for liver disease, and a next-generation treasury strategy managed by Arca Investment Management. This strategy aims to improve capital efficiency and accelerate growth by transforming idle cash into a yield-generating engine. The company's TAEUS® system targets steatotic liver disease and MASH, a massive and underdiagnosed market, aligning with the rapidly expanding GLP-1 therapy market.
3 min readEndra Life Sciences Inc. (NASDAQ:NDRA) announced that its shareholders approved a significant increase in authorized common stock from 20 million to 1 billion shares, alongside the election of four directors, at its 2025 annual meeting. Shareholders also ratified the appointment of RBSM LLP as the independent accounting firm and approved executive compensation on an advisory basis, but rejected a proposal for officer exculpation. These decisions reflect ongoing corporate governance activities and strategic initiatives, including advancements in the TAEUS Liver device and a recent $4.9 million PIPE financing to enhance financial stability and technological capabilities.
4 min readENDRA Life Sciences (NASDAQ: NDRA) is advancing its TAEUS® liver imaging technology, which offers a cost-effective alternative to MRI for diagnosing steatotic liver disease and MASH. The company is also enhancing its capital efficiency through a partnership with Arca Investment Management, generating non-dilutive returns to support clinical validation and commercialization. Recent feasibility study results confirm TAEUS®'s alignment with MRI-PDFF performance, positioning ENDRA for significant market impact in both clinical care and pharmaceutical development.
3 min readENDRA Life Sciences Inc. ( NASDAQ:NDRA ) shares jumped after the company announced $4.9 million in funding commitments from institutional and cryptocurrency investors to launch a new digital asset treasury strategy.
3 min readShares of ENDRA Life Sciences Inc. NDRA rose sharply in pre-market trading after the company announced it will be granted a US patent titled "Radio Frequency Applicator". ENDRA Life Sciences shares jumped 61.4% to $5.58 in the pre-market trading session. Here are some other stocks moving in ...
3 min read
